Seqirus, part of the CSL Group, is the new global company created from the combined strength and expertise of bioCSL and the influenza vaccines business formerly owned by Novartis.

In July 2015, bioCSL and the influenza vaccines of Novartis joined forces to create Seqirus, now the second largest influenza vaccine provider in the world. With extensive research and production expertise and manufacturing plants in the US, UK and Australia, Seqirus is a transcontinental partner in pandemic preparedness and a major contributor to the prevention and control of influenza globally. Seqirus has a workforce of over 2,000 employees, significant manufacturing capacity, and a commercial presence in 20 countries.


Add to Contacts +

Boulevard Industry Park
Gaskill Road
United Kingdom
L24 9GR

Stephanie Birkett
t: 0151 705 5000
f: 0151 705 5018

View Map
Loading Map....